Detalles de la búsqueda
1.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Lancet
; 403(10435): 1460-1471, 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38554725
2.
A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events.
Br J Cancer
; 129(4): 612-619, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37419999
3.
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Br J Cancer
; 128(1): 30-41, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335217
4.
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
Br J Cancer
; 129(2): 309-317, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37237172
5.
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE.
Br J Cancer
; 127(9): 1629-1635, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36008705
6.
Canadian consensus on TRK-inhibitor therapy for NTRK fusion-positive sarcoma.
Int J Cancer
; 149(9): 1691-1704, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34213775
7.
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma.
Future Oncol
; 17(22): 2923-2939, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33855868
8.
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.
Cancer
; 126(7): 1550-1558, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31914209
9.
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors.
Invest New Drugs
; 38(4): 1156-1165, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31734832
10.
High prevalence of persistent emotional distress in desmoid tumor.
Psychooncology
; 29(2): 311-320, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31778588
11.
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
JAMA
; 323(13): 1266-1276, 2020 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32259228
12.
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Br J Cancer
; 128(2): 400, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36697966
13.
Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study.
BMC Cancer
; 16: 30, 2016 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26786213
14.
Pharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT).
Invest New Drugs
; 33(4): 895-900, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25937431
15.
Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study.
Eur J Cancer
; 205: 114119, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38759389
16.
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data.
EClinicalMedicine
; 69: 102443, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38380071
17.
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors.
Cancer Discov
; 14(6): 1048-1063, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38393391
18.
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials.
JCO Precis Oncol
; 7: e2200509, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37027812
19.
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.
Clin Cancer Res
; 29(20): 4128-4138, 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37566240
20.
Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial.
Rare Tumors
; 14: 20363613221100033, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35547106